Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.06
-0.0300-2.75%
Volume:86.84K
Turnover:92.70K
Market Cap:16.05M
PE:-1.43
High:1.09
Open:1.07
Low:1.05
Close:1.09
52wk High:1.80
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:0.64
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:5.94
PE(LYR):-0.86

Loading ...

BioCardia schedules first-quarter earnings conference call, corporate update

Reuters
·
May 12

BioCardia provides update on Helix pre-submission meeting with FDA

TIPRANKS
·
May 09

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 08

BioCardia Inc - FDA Prefers Helix Approval Simultaneous With Cardiamp Cell Therapy System Approval

THOMSON REUTERS
·
May 08

BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Agrees on Two Pathways for Helix Marketing Clearance, No Safety Concerns Raised

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Suggests Follow-on Pre-Submission Could Enable Helix Approval via Denovo Pathway

THOMSON REUTERS
·
May 08

BioCardia CEO Peter Altman acquires 5,000 common shares for $5,550

Reuters
·
Apr 30

BioCardia Gains Japanese Patent for Heart3D Imaging Technology

TIPRANKS
·
Apr 28

BioCardia says Japan allows patent for Heart3D fusion imaging software

Reuters
·
Apr 28

BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3d™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During Cardiamp Cell Therapy Procedures

THOMSON REUTERS
·
Apr 28

BioCardia CEO Peter Altman buys $1,230 common shares

Reuters
·
Apr 23

BioCardia reports ‘positive’ outcome in consult with Japan’s PMDA for CardiAMP

TIPRANKS
·
Apr 20

BioCardia says Japan PMDA deems CardiAMP data sufficient for market clearance

Reuters
·
Apr 20

BioCardia gets Nasdaq notice for failing $2.5 million stockholders’ equity rule

Reuters
·
Apr 16